IMMUNOMEDICS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$256.4M

919 transactions

Summary

IMMUNOMEDICS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $195.8MSales: $18.3M39 insiders

Date	Insider	Type	Value
2020-10-23	Duncan Barbara Gayle	D	—
2020-10-23	Duncan Barbara Gayle	D	—
2020-10-23	Duncan Barbara Gayle	D	—
2020-10-23	BAUM CHARLES M	D	—
2020-10-23	BAUM CHARLES M	D	—
2020-10-23	BAUM CHARLES M	D	—
2020-10-23	Delaney Brendan(Chief Commercial Officer)	D	—
2020-10-23	Freedberg Jared(Gen. Counsel & Corp. Secretary)	D	—
2020-10-23	BALL BRYAN(Chief Quality Officer)	D	—
2020-10-23	BALL BRYAN(Chief Quality Officer)	D	—
2020-10-23	Islam Khalid	D	—
2020-10-23	Islam Khalid	D	—
2020-10-23	Islam Khalid	D	—
2020-10-23	Andrews Kurt J.(Chief Human Resources Officer)	D	—
2020-10-23	ITRI LORETTTA M(Chief Medical Officer)	D	—
2020-10-23	ITRI LORETTTA M(Chief Medical Officer)	D	—
2020-10-23	HUTT PETER BARTON	D	—
2020-10-23	HUTT PETER BARTON	D	—
2020-10-23	HUTT PETER BARTON	D	—
2020-10-23	Azelby Robert	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

IMMUNOMEDICS INC — Contributions, Lobbying & Contracts | Poliscope